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Abstract
Count outcomes occur in virtually all disciplines, such as medicine, epidemiology or
biology, but they often contain error. Recently it has been shown that self-reported
numbers of exacerbations of Chronic Obstructive Pulmonary Disease (COPD) patients
can be considerably miscounted. Motivated by this result, we reanalyzed data from the
Towards a Revolution in COPD Health (TORCH) trial, a large randomized controlled
trial with the self-reported number of exacerbations of COPD patients as outcome.
To adjust for miscounting error in the response of Poisson and (zero-inflated) negative
binomial models we introduce novel, general methodology. The key idea is to formulate
a zero-inflated negative binomial model to capture the error mechanism. This
parametric approach automatically circumvents drawbacks of previously suggested
methodology that treats miscounted outcomes in the misclassification framework.
Prior information for the response error model parameters was elicited from validation
data of an external study, and adaptively weighted to account for potential prior-data
conflict. The results of the Bayesian hierarchical modelling approach indicated that
the treatment effect has been overestimated in the original study. However, closer
inspection revealed that this unexpected result was an artefact of an unaccounted
time-dependency of the treatment effect.
Keywords
Miscounting error; response error; count outcome; zero-inflated negative binomial
regression; Bayesian analysis; randomized clinical trial; prior weighting;
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1 Introduction
Investigating the effects of measurement error (ME) on the parameter estimates
of regression models has a long tradition in the statistical literature1–6. Bias
induced by ME can be classified into attenuation (bias towards zero) and reverse
attenuation (bias away from zero) effects. The vast majority of literature on ME
in regression focusses on error in the covariates, which is also reflected by the
attention given to it by recent monographs on error modelling5–7.
In contrast to the covariates, which are not required to obey any distributional
assumptions and are assumed to be error-free in standard regression methods,
variability in the response is allowed and modelled via the likelihood of
the regression model. In linear regression, for instance, unbiased, additive,
homoscedastic ME in the response of a linear model is simply absorbed in
the variance of the distribution and thus requires no additional modelling
efforts5;8. For heteroscedastic error in a continuous outcome, weighted regression
or generalized least squares methods can be used9, and methods for biased
continuous outcome have been proposed as well10–12. On the other hand, there is
no variance term in logistic regression, for example, that absorbs misclassification
error in the response, and this case thus needs specific treatment. Various methods
have been proposed for this problem13–16, among others an EM algorithm to
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recover unbiased estimates of the odds ratios and their variances17 and a Bayesian
approach18.
In clinical trials, exacerbation numbers are frequently used as a response
variable, for example in the TORCH study19, where the self-counted rate of
moderate COPD exacerbations was included as a secondary endpoint. Recently,
Siebeling, Frei and co-authors20;21 have shown in the context of the International
Collaborative Effort on Chronic Obstructive Lung Disease: Exacerbation Risk
Index Cohorts (ICE COLD ERIC) study that self-counted exacerbation numbers
of COPD patients may contain considerable miscounting error. We therefore focus
in this paper on the effects of miscounted outcomes in standard regression models,
namely Poisson, negative binomial (NB), or zero-inflated negative binomial
(ZINB) models. So far miscounted outcomes have been treated within the
misclassification framework22. Although this approach is extremely flexible, as all
probability entries of the misclassification matrix can, in principle, be estimated
separately from validation data, it has also a number of disadvantages, such as the
large number of parameters that need to be estimated, or that some additional
assumptions about these entries are required, e. g . decaying misclassification
probabilities for more dissimilar values according to some functional form23.
An additional problem is that the dimension of the misclassification matrix
automatically constrains the range of possible true counts.
To overcome such difficulties, we propose a parametric miscounting error model
and formulate a ZINB regression model for the distribution of observed counts as
a function of the true counts. This error model is then embedded in a Bayesian
hierarchical modelling framework, so that posterior marginals of the regression
and error models can be estimated jointly. In the simplest setup the error model
is independent of the covariates, in which case the error is non-differential and
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the observed response is a surrogate for the true response5;24. However, it can be
useful to formulate the response error model in more generality by allowing for
covariate-dependency15;16;18;22, thus differential error. Implications and effects
of differential and non-differential response error and how to model it will be
discussed.
In the application to the TORCH trial we used the information from the
ICE COLD ERIC study to estimate prior distributions for the error model
parameters, i. e. the latter provided us with validation data. However, even when
validation data are collected under similar conditions as the data of interest,
there is some potential for a prior-data conflict25 when transporting error model
parameters from one study to another. A recently suggested prior weighting
approach26 was therefore used to account for such problems. We used a non-
differential model for the miscounting process, which led to a smaller estimated
treatment effect with respect to the results from the original study, indicating that
the effect has previously been overestimated. However, this result is in contrast
to theoretical predictions. Closer inspection of the original regression model from
the TORCH trial revealed that the estimated treatment effect weakened over the
duration of medication. Extending the regression model by adding an interaction
of ‘time under treatment’ with ‘treatment’ changed the direction of the error
correction effect. In addition, the validation data allowed to estimate an error
model with an explicit sex-dependency, which allows for a potentially different
reporting behavior of males and females.
This paper is organized as follows. We will start by introducing the TORCH
trial19. We will then describe the validation dataset extracted from the
ICE COLD ERIC study and illustrate that a ZINB error model for the miscounted
exacerbations numbers captures the error process well. The methods section
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then generalizes ZINB error modelling, which contains Poisson and NB models
as a special case. We discuss potential effects of error in the response, and
describe how the error and regression models can be integrated into a Bayesian
hierarchical model. We then apply the methodology in the subsequent section
to our motivating example. The final section provides some conclusions, and we
discuss the importance, but also possible difficulties, of error modelling.
2 Case study: the TORCH trial
The TORCH trial19 was a large trial of pharmacotherapy in patients with
COPD that lasted for 3 years. The study included 6112 patients in the efficacy
population, of which n1 = 1524 received a placebo and n2 = 1533 a combination
treatment (salmeterol plus fluticasone). Another 1521 patients received only
salmeterol and 1534 received only fluticasone, but these treatment arms were
not included in our analyses. The primary objective of the study was to
demonstrate a significant reduction in all-cause mortality in COPD subjects that
obtained the combination treatment, compared with the placebo group. The
rate of moderate COPD exacerbations was included as a secondary endpoint,
on which our interest centers in this example. The data from the TORCH
study were provided and accessed through the SAS Solutions on Demand secure
portal (https://researchenvadmin.ondemand.sas.com). All statistical analyses
were carried out in the provided Clinical Trial Data Transparency Research
Environment, from where results could then be exported.
The frequency of exacerbations were analyzed in Calverley et al.19 using a NB
model with treatment xi ∈ {0, 1} of patient i, adjusted for region of recruitment
(Eastern Europe, Western Europe, USA, Asia and Pacific, Other), age, sex,
baseline smoking status (yes/no), BMI, number of exacerbations in the 12 months
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prior to screening (categorized as 0, 1, ≥ 2), and baseline disease severity. These
confounder variables were summarized in the vector zi. To account for inter-
individual differences in the time under treatment, the logarithm of the time
log(ti) during which patient i received the allocated treatment in the study was
included as an offset variable27, thus the original regression model was given as
yi ∼ NB (exp(log(ti) + β0 + xiβx + ziβz), θ) . (1)
The probability mass function of the NB(µ, θ) distribution with overdispersion
parameter θ, expected value E(y) = µ and variance Var(y) = µ(1 + µ/θ) is given
in Appendix A. Note that the overdispersion parameter θ is inversely related to
the variance Var(y), and in particular a Poisson distribution with E(y) = Var(y)
is obtained for θ →∞.
The regression parameters β0, βx and βz in (1) are the intercept, the treatment
effect and the parameters of the remaining covariates, respectively. The rate ratio
for treatment vs. placebo was estimated as exp(βˆx) = 0.75 with a 95% confidence
interval of (0.69, 0.81). Note that the formulation of model (1) implicitly assumes
that the response yi represents the correct number of exacerbations for patient i.
As mentioned above, however, the outcome in the analysis of Calverley et al.19
stems from patient self-reports, thus such an assumption does generally not hold.
3 Analysis of validation data
To understand how reported and true values are related, i. e. to formulate an
error model, it is crucial to rely on validation data. Ideally, such data stem from
an internal source of information, for instance when the error-prone variable
is measured according to some “gold standard” for a subset of the investigated
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population. Given that no internal validation data were available in the context
of the TORCH trial, we have extracted such relevant information from the
ICE COLD ERIC study20;21, where self-reported exacerbation numbers of 407
COPD patients were compared to the numbers ascertained by an adjudication
committee who had access to the patients charts of their general practitioners,
patient self-reports and from all follow-up assessments. Denote by y?i the self-
reported number of exacerbations by patient i, while yi is the corresponding true
number of exacerbations. The aggregated validation data are shown in table 1. In
a first attempt, we fitted a NB regression model
y?i | yi ∼ NB(γ0 + γ1yi, θE)
with identity (id) link, regression parameters γ0, γ1 and overdispersion parameter
θE to describe the distribution of the reported counts as a function of the true
counts. To this end, a standard likelihood approach was used. The fact that the
overdispersion parameter was estimated as θˆE = 3.49∞ indicates that an error
model with overdispersion is appropriate for the miscounting error in this study.
Moreover, the estimated overdispersion parameter θˆE was larger than when a
negative binomial model with the more common log link, including log(yi + 1)
as explanatory variable, was used (θˆ = 3.12). Thus, the id link led to a model
with less overdispersion, but also to a better model fit, as reflected by its AIC of
1271 compared to 1288 for the model with log link. However, deviance residuals
indicated that there might be an excessive number of zeroes in the reported counts
(figure 1, left). We therefore replaced the NB distribution of the error model by a
ZINB distribution, leading to
y?i | yi ∼ ZINB (γ0 + γ1yi, pi, θE) , (2)
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with a parameterization as given in Appendix A. The zero-inflation probabilities pi
were related to yi via the logistic transformation logit(pi) = δ0 + δ1I(yi > 0) with
indicator covariate I(yi > 0) = 1 if yi > 0 and 0 otherwise, which led to a better
fit than when directly including yi. Although it might not be directly evident
from the deviance plot (figure 1, right), model (2) resulted in less overdispersion
(θˆ = 6.09) and in an AIC that decreased considerably from 1271 to 1260.
Before combining the error model (2) with the regression model from the
TORCH study, we discuss the novel modelling approach and the effect of
miscounting error in outcomes in more detail, see the next section.
4 Modelling and effects of miscounted outcomes
4.1 Error modelling for count outcomes
A slightly more general formulation of the ZINB error model (2) is given by
y?i | yi ∼ ZINB(µi, pi, θE) , (3)
where the mean µi = h(γ0 + γ1yi) is linked to the true counts yi via a possibly
non-linear (inverse link) function h, and logit(pi) = w
>
i δ depends on a vector wi
of covariates and a vector of regression coefficients δ. The id link is a natural choice
when the true and the observed counts are on the same scale. Note that wi can
often simply be replaced by (1, yi)
>, but we used this more general notation here to
allow for the inclusion of transformed versions of yi and for additional covariates.
If no excessive zeroes are expected, the ZINB regression can be replaced by the
simpler NB model with pi = 0. If in addition θ →∞, the error distribution reduces
to Poisson.
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If the id link is used, the restrictions γ0 ≥ 0 and γ1 ≥ 0 avoid negative expected
values and imply increasing mean and variance for larger true counts. In the
special case of a NB error model with γ0 = 0 and γ1 = 1, model (3) implies
unbiased error, i. e. E(y?i | yi) = yi. However, outcomes with yi = 0 then necessarily
lead to observations y?i = 0, imposing that zero counts are always correctly
reported. If such a restriction is unnatural, it can be avoided by requiring γ0 > 0
to allow for over-reporting in the case yi = 0. This consideration shows that
unbiasedness is not an essential property of count error modelling, as the error
distribution is not naturally symmetrical, in particular for small counts.
The use of a ZINB error model implies that the error variance is Var(y?i | yi) ≥
E(y?i | yi), and equality holds when the model is Poisson, i. e. pi = 0 and θE =∞.
The model thus imposes a minimal variance for the distribution of the observed
counts around the true counts. In some situations such a modelling assumption
could be implausible, in which case the ZINB error model may be replaced by a
count model that allows for underdispersion, for instance the generalized event
count model28 or the generalized Poisson distribution29. However, overdispersion
is not a critical assumption for the error in the response of the TORCH study
that is analyzed here (figure 1).
The formulation of model (3) propagates a non-differential error, i. e. it implies
that the error is independent of the covariates (xi, zi) given the true response yi,
and thus Pr(y?i | yi, xi, zi) = Pr(y?i | yi). In a more general setup y?i may depend
on the covariates (xi, zi), in which case the error in y
?
i is differential. To keep
notation simple, however, we will in the following write the parametric models
without covariate dependencies, except when explicitly needed.
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4.2 The effect of a miscounted response
It is important to understand potential effects of error-prone count outcomes y?i on
the parameter estimates in Poisson, NB or ZINB regression model. As discussed in
section 4.1, error that is generated according to model (3) may induce bias in the
observed counts y?i , thus E(y
?
i | yi) 6= yi, and unbiased error is only retrieved in very
special cases, i. e. when the model is NB with h = id, γ0 = 0 and γ1 = 1. In this
case, the parameter estimates for β0 and βx are unbiased in the naive regression
as well, because log(E(y?i )) = log(E(yi)) = β0 + xiβx. On the other hand, when
γ0 = 0 but γ1 6= 1, the error model is no longer unbiased, but when the standard
log-link is used in the regression model (which is always the case here), the slope
parameter βx can still be consistently estimated, as can be seen from
log(E(E(y?i | yi)) = log(E(γ1yi))
= log(γ1) + log(E(yi)) (4)
= log(γ1) + β0 + xiβx .
Generally, the likelihood for an erroneous observed regression outcome y?i can
be written as
Pr(y?i |xi, zi) =
∑
yi
Pr(y?i | yi, xi, zi) Pr(yi |xi, zi) . (5)
If the error in y?i is non-differential, the expression Pr(y
?
i | yi, xi, zi) can be replaced
by Pr(y?i | yi). If there is no relationship between yi and the covariates (xi, zi),
both terms in (5) are independent of (xi, zi), and thus also y
?
i is independent of
the predictors. A naive regression analysis then leads to valid conclusions about
the association of the predictors with the true response, i. e. if the predictors
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are independent of the response, non-differential error cannot induce a spurious
effect. Still, the resulting tests have decreased power, as discussed by Carroll et
al.5[section 15.4]. Moreover, if the response and the predictors are associated, non-
differential error typically leads to attenuated versions of the true effects, see e. g .
Appendix B for the case that is relevant in this study, although situations with
the opposite consequence, i. e. overestimation of the effect size, can be constructed
(see the end of Appendix B for a hypothetical example).
On the other hand, if the error in y?i is differential, equation (5) shows that
there may be a relationship between y?i and (xi, zi), even if the true response is
not associated with the covariates. Classical hypothesis tests for the regression
parameters βx and βz are then no longer valid and often lead to spurious
significance and reverse attenuation. Finally, a true relation between the covariates
and yi may be masked by a non-differential or a differential error. Hence, the
direction of a potential bias in the parameter estimates induced by the ME in y?i
cannot be predicted in general.
4.3 Bayesian hierarchical model
Consider a regression model with count outcome yi, potentially overdispersed
and/or zero-inflated, and again assume that yi can only be observed via a
miscounted proxy y?i . The error model (3) can then, in principle, be combined with
any count regression model. Here, however, we assume that all extra-variability
and zero-inflation in the measured response is attributed to the miscounting
process. We therefore formulate a hierarchical model that comprises a Poisson
Prepared using sagej.cls
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model for the true observations, and a ZINB error model:
yi ∼ Po (exp(oi + β0 + xiβx + ziβz)) , (6)
y?i | yi ∼ ZINB (h(γ0 + γ1yi), pi, θE) , (7)
where oi = log(ti) denotes the offset, logit(pi) = w
>
i δ, and h is again the inverse
link function of the error model. The Poisson assumption for the regression model
involving the true counts could easily be relaxed by using a NB or ZINB model, but
it may then be difficult to identify the various contributors to the variance of y?i , or
to separate the zero-inflation mechanisms of the regression and the error model, in
particular if only weak prior information is available. Still, such an approach may
be sensible, for instance when there are specific reasons to expect zero-inflation
in the regression model. With respect to the estimates of the regression model
parameters, the choice is not expected to be critical, which is also confirmed by
additional calculations presented in the supplementary material (for results see
Table S1). Independent normal priors with small precision are usually specified
for β0, βx and the components of βz. Information on the parameters of the error
model, namely (γ0, γ1, δ
>)> and θE , must be obtained from (internal or external)
validation data or expert knowledge. If the error model is expected to be covariate-
dependent, it is beneficial if the model parameters can be estimated from separate
validation data (sub)sets.
The marginal distribution of the measured response yi
? following model (6)-(7)
is overdispersed by construction. This also holds if y?i | yi is Poisson distributed,
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i. e. when θE =∞, in which case the marginal expectation and variance of y?i are
E(y?i ) = E(E(y
?
i | yi))
Var(y?i ) = E(Var(y
?
i | yi)) + Var(E(y?i | yi))
= E(E(y?i | yi)) + Var(E(y?i | yi)) .
The last equality holds because variance and expected value are equal under the
Poisson assumption. Thus in general we have Var(y?i ) > E(y
?
i ), i. e. overdispersion.
Therefore, our proposed error modelling framework should only be applied if the
observed counts are (marginally) overdispersed.
A general concern in ME modelling is the aspect of identifiability, namely when
the error model parameters are unknown30. Equation (4), for instance, illustrates
that confounding between γ1 and β0 could be an issue. Interestingly, however,
Gustafson30 has illustrated that already relatively crude priors can be sufficient
to obtain good results if there is enough indirect learning about nonidentifiable
model parameters.
Marginal posterior distributions for the parameters of model (6)-(7) can be
obtained by MCMC sampling. A simulation example including code is given
as online supplementary material (files 2 and 3). Unfortunately, as the latent
variable y = (y1, . . . , yn)
> is not Gaussian, it is not possible to approximate the
posterior marginals by integrated nested Laplace approximations (INLA), which
are a computationally convenient alternative to sampling approaches for Bayesian
inference in latent Gaussian models31, in particular in the presence of covariate
measurement error32.
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5 Application to the TORCH study
5.1 Non-differential response error modelling
In this section, we use the prior information derived from the ICE COLD ERIC
study to reanalyze the TORCH data. We thus eventually apply the modelling
framework as given in (6)-(7) by combining the ZINB error model with id link
and a Poisson regression model to obtain corrected estimates for the effect βx of
the combination treatment in the TORCH study. The hierarchical model now is
yi ∼ Po (exp(log(ti) + β0 + xiβx + ziβz)) ,
y?i | yi ∼ ZINB (γ0 + γ1yi, pi, θE) ,
with logit(pi) = δ0 + δ1I(yi > 0). The model thus essentially estimates only two
distinct zero-inflation probabilities, namely one for individuals with yi = 0 (i. e.
those patients that had no exacerbation), and one for those with yi > 0.
Prior information on the error model parameters α = (γ0, γ1, δ0, δ1) and θE was
obtained as described in Section 3, i. e. by fitting model (2) to our validation data
without stratification for treatment or any additional covariates. The miscounting
error in the reported exacerbation counts was thus assumed to be non-differential
in this first error model. Maximum-likelihood estimates of the error model
parameters α and the corresponding covariance matrix Σ were given as
αˆ = (0.753, 0.966, 0.151,−3.174)> , (8)
Σˆ =

0.020 −0.007 0.033 −0.019
−0.007 0.007 −0.011 0.018
0.033 −0.011 0.122 −0.094
−0.019 0.018 −0.094 0.401

. (9)
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It would be tempting to use Gaussian priors for α with moments as estimated
in (8) and (9). However, by doing this we would postulate that the error model
deduced from the ICE COLD ERIC study is transportable to the TORCH study,
i. e. that the mechanisms inducing the misreporting are exactly the same in
both datasets. At first glance this seems to be a plausible assumption as both
datasets were collected over the same duration of three years, and the mean
number of reported exacerbations were similar (2.02 in the validation data and
2.19 in the TORCH study). However, such an assumption can still lead to a prior-
data conflict, indicated for instance by a low Box’s p-value25, particularly if the
conditions under which the validation data were collected differ from the study
conditions, which is difficult to verify. In our example, the operationalization of
exacerbation measurements might deviate among the studies, or the ensembles
could encompass a different mixture of ethnicities or disease severities. We
therefore used a recently suggested approach by Held and Sauter26, termed
adaptive prior weighting, which at the same time identifies and accounts for a
potential prior-data conflict. The idea is to multiply the covariance matrix from
the validation data with an unknown scalar g > 0, leading to the prior
α | g ∼ N(αˆ, gΣˆ) , (10)
with a uniform prior for
g
g + 1
∼ U(0, 1) , (11)
i. e. a hyper-g prior33;34 for g. This design allows to adaptively weight the prior
distribution with weight w = 1/g. Values of w < 1 (i. e. g > 1) then indicate that
the prior distribution is downweighted due to a prior-data conflict, and the prior
distribution becomes flatter. On the other hand, values w > 1 (i. e. g < 1) increase
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the weight of the prior by narrowing the prior distribution, which suggests that the
prior is in good agreement with the data26. The overdispersion parameter θE was
estimated from the validation data as θˆE = 6.09 with a standard error of 2.03. A
log-normal prior distribution θE ∼ LN(log(6.09), 0.332) was therefore used, where
the second argument is the squared standard error, calculated using the delta-
rule: se(log(θˆE)) = 2.03/6.09 = 0.33. Finally, independent N(0, 10
2) priors were
assigned to the components of β = (β0, βx,β
>
z )
>.
A Bayesian analysis using MCMC was performed in JAGS via the R-interface
rjags35;36 by running two parallel chains for 25 000 iterations each, with a
burn-in of 2 500 and a saving frequency of 5, and both chains were used for
estimation. The posterior mean of the rate ratio for treatment vs. placebo was
exp(βˆx) = 0.80 with a 95% credible interval (CI) ranging from 0.72 to 0.89. The
graph labelled as Corrected in figure 2a) depicts this estimate in comparison to
the uncorrected estimate exp(βˆx) = 0.75 with 95% confidence interval (0.69, 0.81)
from Calverley et al.19. Error-correction hence led to an estimate closer to 1, i. e.
to a less pronounced treatment effect. Analytical considerations however show
that non-differential response error in the model used here necessarily leads to
attenuation effects, see Appendix B, while a correction towards 1 would imply
that the error caused reverse attenuation. Thus, if the error model was specified
correctly, we would expect a correction in the opposite direction of what is
observed here, indicating that either the model did not correctly capture the
error structure, or that there is an error in the model formulation. This concern
is also supported by the posterior of g with a median of 33.3 (95% CI: 4.76,250),
meaning that the weight of the prior was substantially decreased by a median
factor of wˆ = 1/gˆ = 0.03 (95% CI: 0.004 to 0.21). Even without prior weighting
(g = 1) the treatment effect was estimated as 0.79 (95% CI: 0.71 to 0.88), and
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also the assignment of a fixed prior to α, i. e. by setting g = 0, did not change
the quality of the result (estimate 0.78, 95% CI: 0.71 to 0.87).
In order to better understand the TORCH data structure, the same analysis was
carried out separately on three subgroups of patients. The first group consisted
of the 1973 patients that were under treatment for the duration of at least 2.5
years (the maximum duration was 3.1 years). The naive analysis for this group
resulted in an estimated treatment effect of exp(βˆx) = 0.89 (95% CI: 0.72 to 1.10).
MCMC was then used to fit the error model with the same model parameters as
in equations (8) and (9) and prior weighting according to (10) and (11), which
yielded an estimate of exp(βˆx) = 0.82 (95% CI: 0.70 to 0.94). The same direction of
the correction was observed for the second group of 522 patients with a treatment
time between 1 and 2.5 years (naive estimate of exp(βˆx) = 0.80, 95% CI: 0.63
to 0.92 vs. error-corrected estimate of 0.70, 95% CI: 0.51 to 0.92), and for the
third group of 653 patients that were under treatment for ≤ 1 year (naive and
error-corrected estimates equal to 0.58, 95% CI from 0.48 to 0.71, and 0.52,
95% CI from 0.34 to 0.74, respectively). All estimates and their uncertainties
are shown in figures 2b)-d). The results illustrate two things: First, the observed
treatment effect gradually weakens over time. And second, the effect becomes
stronger after error-correction within the three subgroups. This indicates that the
above finding, where the treatment effect weakened upon error correction, was
indeed the consequence of a model misspecification. It is not straightforward to
isolate the origin of the observed time-dependency in the treatment effect. A likely
explanation is that the data suffer from a so-called emigrative selection bias 37,
which emerges when withdrawing rates in the placebo and the treatment groups
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differ, and when at the same time withdrawing patients tend to have more severe
disease, which was exactly the case in the TORCH trial19;38.
Given that the scope of the present paper is to address miscounting error and not
that of selection bias, a simple and pragmatic way to capture the time-dependency
of the treatment effect is to include an interaction between the treatment xi
of patient i and the (log-transformed) time under treatment ti. Therefore, we
extended the original model (1) that was used in the analysis of the TORCH trial
by an interaction term xi log(ti) and a main effect log(ti):
yi ∼ Po (exp(log(ti) + β0 + xiβx + xi log(ti)βxt + log(ti)βt + ziβz)) , (12)
where βxt and βt are the respective slope parameters. Importantly, the ∆AIC
between the original model (1) and the extended model (12) is -275 for the
likelihood analysis without error modelling, indicating a very clear improvement
of the model fit. Model (12) was then again enhanced with the error model as
specified in equations (8)-(11), and the posterior distribution was estimated via
MCMC sampling, using the same length and number of chains. The treatment
and interaction effects of model (12) without error modelling were then given
as exp(βˆx) = 0.74 (95% CI: 0.66 to 0.83) and exp(βˆxt) = 1.14 (95% CI: 1.03
to 1.27), while error correction lead to exp(βˆx) = 0.70 (95% CI: 0.57 to 0.86),
with exp(βˆxt) = 1.18 (95% CI: 0.97 to 1.44). This means, as an example, that
for a treatment time of ti = 1 (in years), the treatment effect is corrected from
0.74 to 0.70, while for ti = 3, the effect changes from 0.86 to 0.84. Overall, error
correction was now in the expected direction, meaning that the treatment effect
is underestimated when miscounted outcomes are used without any correction.
Interestingly, the regression parameter βt was negative, both in the model with
and without error considerations (βˆt = −0.50, 95% CI from -0.56 to -0.45 without
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error modelling, and βˆt = −0.33, 95% CI from -0.45 to -0.19 with error modelling),
which reflects that patients with severe disease were more likely to withdraw
from the study38. The posterior median of the prior weight wˆ of the error model
parameters was now 0.07 (95% CI from 0.01 to 0.34), thus slightly larger than
when using the regression model without interaction term, although there is still
indication for a prior-data conflict that cannot be resolved with the available
datasets.
5.2 Differential response error modelling
Interestingly, our validation dataset provided information on the sex of the
patients, and it was thus possible to estimate the error model components
separately for females (n1 = 176 patients) and males (n2 = 231 patients). The
respective data are given in tables S2 and S3 of the supplementary pdf file. The
sex-specific parameter estimates and covariance matrices were then
αˆ(1) = (0.688, 1.064,−0.356,−12.811) , (13)
Σˆ(1) =

0.041 −0.017 0.097 −0.006
−0.017 0.017 −0.040 0.120
0.097 −0.040 0.470 −0.180
−0.006 0.120 −0.180 55370

, (14)
Prepared using sagej.cls
Muff et al. 21
for females and
αˆ(2) = (0.824, 0.878, 0.502,−2.799) , (15)
Σˆ(2) =

0.036 −0.012 0.046 −0.030
−0.012 0.009 −0.014 0.017
0.046 −0.014 0.155 −0.132
−0.030 0.017 −0.132 0.308

(16)
for males, with overdispersion parameters estimated as θˆ
(1)
E = 4.13 (se = 1.33) and
θˆ
(2)
E = 14.71 (se = 12.18). Note that the large variance for the parameter δ1 in the
female group (the entry in the lower right corner of matrix (14)) indicates that
the respective parameter is essentially nonidentifiable. This problem could arise
because the zero-inflation probability for females with true exacerbations yi > 0
was essentially zero, i. e. females did then not report excessive zeroes, so that δ
(1)
1
becomes small, and thus difficult to be estimated. An additional model checking
step then revealed that the error distribution for the female group can be described
by the simpler NB model, i. e. ignoring zero-inflation (AIC for NB: 591, AIC for
ZINB: 592), while the ZINB model is needed for the males (AIC improvement
from 681 to 669 when changing from NB to ZINB). The ZINB error model (13)-
(14) for females was thus replaced by the simpler NB model, (which corresponds
to pi = 0 for female patients), and the remaining parameters were estimated as
αˆ(1) = (γˆ
(1)
0 , γˆ
(1)
1 ) = (0.421, 1.183) , Σˆ
(1) =
 0.007 −0.003
−0.003 0.012
 , (17)
and θˆ
(1)
E = 3.74 (se = 1.16). The sex-dependent error in the response was then
modelled using the estimates and covariance matrices as given in (15),
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(16) and (17), with log-normal priors θ
(1)
E ∼ LN(log(3.74), 0.312) and θ(2)E ∼
LN(log(14.71), 0.832), again applying the delta-rule to obtain the variances. As
before, the covariance matrices Σ(1) and Σ(2) were adaptively weighted by scalars
g1 and g2, which were given hyper-g priors as in (11) in order to account for a
potential prior-data conflict.
Posterior distributions were again estimated with MCMC using the same
setup as above, but running the chains for 100 000 iterations each to ensure
convergence. The posterior means for the treatment and interaction effects were
given as exp(βˆx) = 0.69 (95%-CI: 0.56 to 0.84) and exp(βˆxt) = 1.19 (95% CI: 0.98
to 1.45), respectively. Median prior weights for the two groups were estimated
as wˆ1 = 0.50 (95% CI: 0.03 to 15.26) and wˆ2 = 0.06 (95% CI: 0.01 to 0.30),
still indicating some prior-data conflict in the male subgroup. Interestingly, the
switch from a non-differential to a covariate-dependent response error model did
essentially not change the results, thus a non-differential model would be sufficient
here. Still, the exercise illustrates that covariate-dependent error modelling is
conceptually straightforward, given that prior information is available.
6 Simulation study
The error analysis of the TORCH trial did not only reveal a time-dependency
of the treatment effect of the originally presented regression model, but also
illustrated that error-modelling on top of a misspecified regression model may
lead to corrections of effect estimates that are in an unexpected or even wrong
direction. It is useful to perform three simulations to illustrate that (i) error
modelling as proposed here leads to unbiased estimates of the true effects, given
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that all modelling assumptions are fulfilled, and that (ii) the effects observed
in the error analysis of the TORCH study may indeed originate from a model
misspecification, such as an omitted time-dependency of the treatment effect. In
each example, n = 2000 count outcomes yi were generated in dependence of a
treatment indicator x with xi = 0 for i = 1, . . . , 1000 and xi = 1 otherwise, and
an offset log(ti) such that ti was uniformly distributed between 0.1 and 3. In all
simulations, miscounting error in yi was generated according to the ZINB error
model
y?i | yi ∼ ZINB (γ0 + γ1yi, pi, θE) (18)
with logit(pi) = δ0 + δ1I(yi > 0) and error model parameters (γ0, γ1, δ0, δ1) =
(0.2, 1.2, 0.15,−3) and θ = 4, which were chosen to be comparable to the values
observed in the TORCH study. Each simulation was repeated 250 times. In each
iteration, parameter estimates for the treatment effect βx from the following three
models were stored:
(i) the maximum likelihood (ML) estimate including the data without error in
the response, leading to the ‘error-free’ estimate.
(ii) the ML estimate using the data with miscounting error in the response,
leading to the ‘naive’ estimate.
(iii) the posterior mean of an MCMC sample for the respective Bayesian
hierarchical error model with a burn-in of 1000 and a sampling of 5 000
iterations, leading to the ‘corrected’ estimate. To this end, the data-
generating error model (18) was used with point priors for the error model
parameters (γ0, γ1, δ0, δ1) = (0.2, 1.2, 0.15,−3), and log-normal priors θE ∼
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LN(4, 1). Independent zero-mean Gaussian priors with a variance of 102 were
specified for the slope parameters of the regression.
ML estimates were obtained using the glm.nb() and glm() functions in R, while
MCMC samples were generated in rjags. ML estimates or posterior means with
2.5% and 97.5% quantile intervals from the 250 iterations were then plotted in
figure 4.
Simulation 1: Simple regression model
In the first example, the regression model was given as
yi ∼ Po (exp(log(ti) + β0 + xiβx)) ,
with regression model parameters (β0, βx) = (1, log(0.7)). The estimates from
analyses (i)-(iii) were stored in each iteration and displayed as boxplot
representations in figure 4, left. The results illustrate that miscounting error
leads to an attenuated version of the estimated treatment effect, but that the
hierarchical error model retrieves unbiased estimates of the true effect.
Simulation 2: Time-dependent treatment effect, wrong model
In this second example, the true counts yi were generated according to the
regression model
yi ∼ Po (exp(log(ti) + β0 + xiβx + log(ti)xiβxt)) (19)
with parameters (β0, βx, βxt) = (1, log(0.7), 0.2). Analyses (i)-(iii) were then
carried out, however choosing the regression model that did not include the
interaction term log(ti)xi, that is, βxt was (erroneously) set to zero, while the
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offset log(ti) was included correctly. Please note that here (ii) and (iii) correspond
to the original analysis that was carried out in the TORCH study without error
modelling, and to the error-correction approach described in Section 6 where no
time-dependency was included in the regression model. The results in the middle
panel of figure 4 confirm the pattern that was observed in Section 6: The naive
analysis leads to treatment effects that are stronger than when correct responses
are included in the regression model. Moreover, error-correction leads to weaker
overall effect estimates, that is, a correction towards the Null.
Simulation 3: Time-dependent treatment effect, correct model
In this last case data were again generated according to model (19), but this
time the correct regression model was included in all analyses. The regression
model (19) was then used (i) once with correct yi, (ii) once with naive response
y?i , and (iii) once for the respective hierarchical error model. Cases (ii) and (iii)
correspond to the naive and error-corrected versions of the TORCH analysis when
the interaction term xi log(ti) was added to the model. The results in the right
panel of figure 4 confirm that non-differential response error leads to an attenuated
treatment effect estimate, and that error analysis is able to properly correct for
it.
7 Discussion
We have proposed a novel statistical framework to treat error in count outcomes
by formulating a ZINB error model. This parametric model only requires prior
elicitation on a few model parameters, and does not artificially limit the range
of the true counts, in contrast to previously suggested methodology22. We
have shown how a Bayesian hierarchical model, including a Poisson regression
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model and a ZINB error model, can be employed to jointly estimate posterior
marginals via MCMC sampling. The development of the methodology proposed
here was motivated by the TORCH trial, where the efficacy of a treatment on the
exacerbation rate of COPD patients was studied by regressing the exacerbation
numbers from patient self-reports on the covariates using a NB model19. In an
external study, these self-reported values have recently been shown to suffer from
considerable miscounting error20;21, thus the respective data could be used to
formulate a count error model. A ZINB regression model of observed vs. true
counts captured the error in the self-reported values reasonably well (figure 1),
and informed priors for the respective model parameters could be extracted at the
same time. Note that the model imposes a minimal error variance Var(y?i | yi) ≥
E(y?i | yi), which in fact appears to be suitable in our case, but may sometimes be
inappropriate. Underdispersed count models might then be a solution, although
we have not discussed them here.
When accounting for error in the outcome of the TORCH study using the
proposed error model, the corrected treatment effect became weaker, indicating
that it had been overestimated in the original study. Only thanks to closer
inspection of the original regression model it became evident that this correction
was an artefact of an unaccounted time-dependency of the treatment effect. This
time-dependency, in turn, could itself be an artefact of non-random withdrawings
(patients with severe disease withdrawings more often), which are known to
potentially lead to biased estimates of model parameters. Accounting for such an
emigrative selection bias would require a thorough understanding of withdrawing
patterns, as well as additional modelling steps, but this is not the scope of
this work. Therefore, the time-dependency was captured by a simple interaction
term. Using this adapted model, error correction led to an increased effect size
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estimate. This example clearly illustrates that error modelling is sensitive to model
misspecifications, and that unexpected bias corrections may therefore help to
discover relevant problems.
Most applied researchers are aware of biases induced by ME in covariates or in
the response of regression models, it is often assumed that the observed effects are
then conservative estimates of the true effects. However, this implicitly postulates
certain types of error structures in the observed variables, typically non-differential
ME. Although this assumption seems to hold in the case study presented here, it
may be violated more often than believed. In fact differential error sometimes
emerges unexpectedly. As an example, Mwalili et al.22 have shown how the
combination of miscounted values from several examiners in an oral health study
leads to differential error globally, even if the miscounting process of each examiner
is non-differential. Similarly, Gustafson7 illustrated how the categorization of a
continuous covariate suffering from non-differential ME can induce a differential
misclassification error. The fact that such an error may lead to nonconservative
estimated effects in clinical or epidemiological studies is critical and should not
be ignored. An example of how to capture covariate-dependent ME was presented
in Section 5.2.
A necessary prerequisite for any error modelling attempt is the availability of
validation data. Here, we have emphasized that the elicitation of suitable priors
for error model parameters can be challenging, and that priors derived from
external validation data may introduce some prior-data conflict into the model
of interest. An implicit assumption in the context of prior information transfer
typically is that such validation data are transportable among studies, i. e. that
the circumstances under which the validation and the study data were collected
are comparable, as the information in the validation data does otherwise not lead
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to sensible priors for the study data analysis. In our example the validation and
study data were collected over the same duration (three years), and the reported
exacerbation numbers were comparable. Still, it will usually be impossible to
check such transportability premises. We have therefore suggested to adaptively
weight the error model priors using a hyper-g prior to ensure that they are
automatically downweighted in the presence of a prior-data conflict, i. e. when
the transportability assumption is questionable. In this case study exactly such a
down-weighting effect was observed, and we can only hypothesize why this was the
case. Possible explanations could be differences in the composition of the study
ensembles regarding, e. g . cultural or health state, or distinct standard operating
procedures to assess exacerbations. Importantly, such transportability concerns
could be mostly eliminated if internal validation data were available.
In conclusion, we have discussed that error in count outcomes may bias
parameter estimates of regression models, and that the bias may be in any
direction. The importance and also some difficulties of error modelling were
highlighted, particularly in the context of clinical trials, where a crucial
assumption is that effect estimates originate from conservative estimation
procedures. We have introduced a parametric miscounting error modelling
framework that is able to treat unbounded counts and seems to capture the
error mechanism in the miscounted outcome of our case study reasonably
well. Advantages and limitations of this novel approach were discussed, and in
particular we recommend to check whether (or to justify why) the ZINB error
model gives a realistic description of the miscounting process under consideration.
Nevertheless, probably the best way to circumvent expensive and tricky error
modelling procedures is to directly optimize the quality of the data. It is not
surprising that Breslow (2014) wrote39:“Obviously, [...] the best method of dealing
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with measurement error was to avoid it!” In the example of the TORCH study
this could have been achieved by replacing patient self-reports by ascertained
values obtained from an adjudication committee. Although this will obviously
lead to higher costs per patient, such an extra effort may be worthwhile: Not only
are more valid effect estimates expected, but also smaller sampling sizes might
be sufficient thanks to the removal of uncertainty (i. e. error), leading to lower
overall costs.
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Figure 1. Deviance residuals versus fitted values of the negative binomial (left) and the
zero-inflated negative binomial regression (right) using the validation dataset, where the
centrally adjudicated exacerbation counts were fitted against the respective patient self
reports. A small jitter has been added to both the fitted values and the residuals. The red
line gives a standard lowess smoother and shows some evidence for zero-inflation.
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Figure 2. Naive and error-corrected estimates for the treatment vs. placebo rate ratio
exp(βx) of exacerbation rates in the TORCH trial. The horizontal lines represent 95%
confidence/credible intervals. The x-axis is given in log-scale. a) “Corrected” shows the
result for the case when non-differential error modelling was carried out on top of the
original regression model used in the TORCH study. Panels b)-d) show the respective
results for the subset of patients with a treatment time of > 2.5 years, between 1 and 2.5
years, and ≤ 1 year, respectively.
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Figure 3. Time-dependent effect estimates of exacerbation rates for naive and
error-corrected treatment vs. placebo rate ratios, calculated as exp(βˆx + βˆxt log(t)).
Dashed lines indicate pointwise 95% CIs, and the black dash-dotted line refers to a rate
ratio of 1 (no effect). The y-axis is given in log scale.
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Figure 4. Boxplots for the ML estimates of error-free and naive estimates, as well as for
the posterior means for the error-corrected estimates of the treatment vs. placebo rate ratio
exp(βx). Each boxplot was generated from the 250 iterations of the simulations. Note that
the x-axis is given in log-scale.
0 1 2 3 4 5 6 7 8 9 10 11 12
0 127 24 5 4 2 2 1 0 0 0 0 0 0
1 26 40 5 2 1 3 0 0 0 0 0 0 0
2 9 17 10 4 2 1 0 0 0 0 0 0 0
3 3 6 7 10 2 3 2 1 0 0 0 0 0
4 1 7 3 6 2 3 2 1 0 0 0 1 0
5 0 3 5 4 0 4 1 1 0 0 0 0 0
6 0 2 4 1 6 1 2 0 0 0 0 0 0
7 0 2 2 0 2 0 0 0 0 0 0 0 0
8 0 0 0 2 2 0 1 2 1 0 0 0 1
9 0 0 0 1 0 0 0 1 1 0 0 0 0
10 0 0 0 0 0 1 0 0 0 0 0 0 0
11 0 0 0 0 0 0 0 0 0 0 0 0 0
12 0 0 0 0 0 2 0 0 2 0 0 0 0
13 0 0 0 0 0 1 1 0 0 0 0 0 0
14 0 0 0 0 1 0 0 0 0 0 1 0 0
15 0 0 0 0 0 0 0 0 0 0 0 1 0
Table 1. Validation data on miscounting. Shown is the total number of centrally
adjudicated exacerbations per patient (columns) by the total number of self-reported
exacerbations per patient (rows).
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Appendix A
A negative binomially distributed random variable y ∼ NB(µ, θ) can be
parameterized in various ways. Here, we used
Pr(y = k) =
Γ(θ + k)
k! Γ(θ)
(
θ
θ + µ
)θ (
µ
θ + µ
)k
, k = 0, 1, 2, . . . .
The parameter θ thus accounts for overdispersion, with smaller θ leading to more
overdispersion, and the Poisson distribution is the limiting distribution for θ →∞.
In the presence of an inflated number of zeroes, the NB distribution can be
generalized to a ZINB distribution, given as
Pr(y = k) =
 p+ (1− p)
(
θ
θ+µ
)θ
, k = 0
(1− p)Γ(θ+k)k! Γ(θ)
(
θ
θ+µ
)θ (
µ
θ+µ
)k
, k = 1, 2, . . .
with mean E(y) = (1− p)µ and variance Var(y) = (1− p)µ(1 + pµ+ µ/θ). Note
that for p = 0 the NB distribution is retrieved, and if in addition θ →∞, the
distribution reduces to Poisson.
Appendix B
Consider the hierarchical model (6)-(7), for simplicity (and without loss of
generality) with βz = 0, zero offset (oi = 0 for all i), and id link for the error
model. Let us start with the case without zero-inflation, i. e. pi = 0. The rate
ratio of the true treatment effect is then given as
exp(β0 + βx)
exp(β0)
= exp(βx) ,
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whereas the expected value of the naive estimate is
γ0 + γ1 · exp(β0 + βx)
γ0 + γ1 · exp(β0) .
To show that the naive estimate is always attenuated, i. e. biased towards 1, we
distinguish two cases.
Case 1: βx < 0
Then exp(βx) < 1, and therefore
γ0 > γ0 exp(βx) .
Adding γ1 exp(β0 + βx) on both sides gives
γ0 + γ1 exp(β0 + βx) > γ0 exp(βx) + γ1 exp(β0 + βx)
= exp(βx) · (γ0 + γ1 exp(β0)) ,
so
γ0 + γ1 · exp(β0 + βx)
γ0 + γ1 · exp(β0) > exp(βx) , (20)
which shows that the naive estimate of βx is biased upwards. Moreover, the naive
estimate is bounded by 1, which shows that it is biased towards 1, thus βx is
biased towards 0.
Case 2: βx > 0
In this case, exp(βx) > 1, and exactly inverted arguments as in case 1 show that
the naive estimate of βx now lies between 1 and exp(βx), i. e. is biased towards
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1. We thus have attenuation of the rate ratio.
All these considerations need to be extended to the case when zero-inflation
is present. The expected values E(y?i | yi) of the naive estimates must then be
multiplied by (1− pi), where pi is the zero-inflation probability for individual i. If
the zero-inflation probabilities pi were independent on the true counts yi, so that
pi = p for all i, the expected values of the naive model need to be multiplied by
(1− p) in the nominator and the denominator of (20), so that inequality is then
still correct. The effect of non-differential error in the case with constant p is thus
still attenuation.
Finally, let us look at the case with zero-inflation probabilities pi that follow
model logit(pi) = δ0 + δ1I(yi > 0) as in the TORCH study. We take the realistic
assumption that the occurrence for excessive zeroes decreases (or at least does
not increase) for larger true counts yi, i. e. that δ1 ≤ 0, which is fulfilled here,
see the respective prior means in (8), (13) and (15). Going back to case 1 above,
assuming βx < 0, we have that the expected number of counts is smaller for a
patient without treatment, so that also the probability that excessive counts are
reported decreases for treated patients, i. e. p
(1)
i ≤ p(0)i , with p(1)i indicating the
zero-inflation probability for a patient with treatment and p
(0)
i the respective value
for a patient without treatment. Therefore 1− p(1)i ≥ 1− p(0)i , and thus
(1− p(1)i )(γ0 + γ1 · exp(β0 + βx))
(1− p(0)i )(γ0 + γ1 · exp(β0))
≥ γ0 + γ1 · exp(β0 + βx)
γ0 + γ1 · exp(β0) > exp(βx) ,
where the last inequality was taken from (20).
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Again, for case 2 with βx > 0 simply invert the arguments.
The above assumption δ1 ≤ 0, although reasonable in our application to the
TORCH study, is critical to show that non-differential miscounting error induces
an attenuation effect in the hierarchical error model used here. In fact, if observed
counts were generated artificially according to a ZINB model with zero-inflation
δ1 > 0 (i. e. more zero-inflation for larger true counts), one can construct cases
with overestimated treatment effects, thus reverse attenuation.
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